World Class Returns with Midcontinent Roots.
Research Bridge Partners has developed a novel means of bridging two of America’s most productive resources –
our research universities and the commercialization centers in the Bay Area and Boston. We make formative investments in biomedical startup companies based on the breakthroughs of preeminent innovators at mid-continent research universities—creating high quality investment opportunities that are sourced from geographies with thinner commercialization resources.
Founded by Isaac Barchas and Reid Hoffman, we use proprietary analytics to identify the less than 1% of academic researchers nationwide whose science and entrepreneurial mindsets are characteristic of successful biomedical startups. We then make seed capital and scaling investments and establish effective corporate structures to create portfolio-ready opportunities for downstream investors.
We invest both not-for-profit and for-profit and capital. While both types of capital reside in separate funds, they nevertheless complement one another in the overall financial returns on our investments. The not-for-profit capital underwrites the cost of identifying and readying individual startup opportunities for downstream investors, whereas the for-profit capital enhances the returns on program related investments.
The various returns on our investments match the expectations of our individual partners.
Downstream investors, including institutional investors, family offices and philanthropic foundations, target gains that are on par with those produced by leading biomedical funds.
Innovators at midcontinent universities optimize the value of their breakthroughs for the benefit of people everywhere, as well as themselves, their colleagues, and their students.
Midcontinent universities enhance their licensing revenue and institutional stature, along with their ability to attract and retain leading innovators as faculty members.
CEOs and other scaling business talent capitalize on extraordinary opportunities to use their talents and experience in increasing human health and wellbeing.
We invest both not-for-profit and for-profit capital to enable investors to achieve their investment objectives—financial, societal, or a combination thereof.